MedPath
NMPA Approval

Edaravone Injection

国药准字H20193238

May 11, 2024

Drug Information

依达拉奉注射液

注射剂

20ml:30mg

化学药品

May 11, 2024

Company Information

Applicant Company

海南省海口市保税区A06-2

Manufacturing Company

海南省海口市保税区A06-2

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

依达拉奉注射液 - NMPA 批准文号 | MedPath